Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Cooper Plaza
Camden, NJ
Camden, NJ 08103Phone+1 856-735-6209
Summary
- Dr. Christina Chu is a gynecologic oncologist in Camden, NJ and is affiliated with MD Anderson Cancer Center at Cooper. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 22 years. She specializes in gynecologic oncology and is experienced in the multidisciplinary treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers and preinvasive disease. Her practice encompasses surgical treatment as well as administration of chemotherapy, as well as clinical trials for cancer treatment. She has more than 60 publications and over 500 citings.
Education & Training
- University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 1999 - 2002
- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1995 - 1999
- Perelman School of Medicine at the University of PennsylvaniaClass of 1995
Certifications & Licensure
- NJ State Medical License 2004 - 2025
- PA State Medical License 1996 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Ovarian Cancer and Immune Response to Flu Vaccine Start of enrollment: 2006 Oct 01
- Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients Start of enrollment: 2005 Aug 01
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- 195 citationsNCCN Guidelines Insights: Cervical Cancer, Version 1.2020.Nadeem R. Abu-Rustum, Catheryn M. Yashar, Sarah M. Bean, Kristin A. Bradley, Susana M. Campos
Journal of the National Comprehensive Cancer Network. 2020-06-01 - 15 citationsImmunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccineChristina S. Chu, Jean D. Boyer, Abbas F. Jawad, Kenyetta McDonald, Wade T. Rogers
Vaccine. 2013-11-04 - 18 citationsTissue-based immune monitoring II: Multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinomaA.R. Hagemann, Ian S. Hagemann, Mark G. Cadungog, Wei-Ting Hwang, Priya Patel
Cancer Biology & Therapy. 2011-08-15
Press Mentions
- Temple Physicians Learn Mindfulness to Cope with the Trauma of Treating COVIDJuly 4th, 2021
- HPV in Pregnant Women Linked to Miscarriages & Preterm Births, Study ShowsMarch 5th, 2020
- HPV Tied to Miscarriages and Preterm BirthsMarch 4th, 2020
- Join now to see all
External Links
- Christina Chu MD, Fox Chase Cancer Centerhttps://www.foxchase.org/christina-chu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: